4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001209191-23-018531
EVP, R&D and CSO acquired 316,410 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morisset Valerie EVP, R&D and CSO | 2023-03-10 | Option exercise | +255,219 | $0.00 | $510 | 405,541 | D |
| Morisset Valerie EVP, R&D and CSO | 2023-03-10 | Option exercise | +61,191 | $0.00 | $12 | 466,732 | D |
| Derivatives | |||||||
| Morisset Valerie EVP, R&D and CSO | 2023-03-10 | Option exercise · Stock Option (Right to Buy) | −255,219 | 5,431 | D | ||
| Morisset Valerie EVP, R&D and CSO | 2023-03-10 | Option exercise · Stock Option (Right to Buy) | −61,191 | 61,190 | D | ||
Loading xslF345X03/doc4.xml…